Other treatments have varying degrees of limitations and adverse effects, for example, intravitreal injections of anti-vascular endothelial growth factor (VEGF) drugs not only fail to completely inhibit the progression of DR, but frequent injections lead to an increased incidence of endophthalmitis (5). This evidence concerns the gene VEGFA and endophthalmitis.